Infinium Pharmachem Limited
ListedSMEPharmaceuticals & Healthcare · NSE
Incorporated in 2003, Infinium Pharmachem Limited manufactures and supplies Iodine Derivatives, APIs, and iodination reaction-based bulk drugs. The company offers R&D services along with commercial-scale manufacturing and packaging for the pharmaceutical, agrochemical, nutraceutical, specialty chemicals, and other chemical industries. Its FDA-certified and GMP-compliant manufacturing facility in Gujarat spans 4,100 sq. m and is equipped to produce complex iodine derivatives. Infinium Pharmachem serves over 15 countries globally, offering more than 200 iodine derivatives and 7 APIs.
Price Band
₹135
Issue Size
₹25.26 Cr
Lot Size
1000 shares
GMP
—
Est. Listing
₹135
at current GMP
Subscribed
1.84x
overall
Open
31 Mar 2023
Close
5 Apr 2023
Allotment
11 Apr 2023
Refund
12 Apr 2023
Demat Credit
13 Apr 2023
Listing
17 Apr 2023
Last updated 12 days ago
Key Highlights
- •Leading player in the Pharmaceuticals & Healthcare segment
- •Price band established at ₹135 - ₹135 per equity share
- •Minimum bid lot is 1000 shares
- •Estimated listing target of ₹135 based on current grey market activity